Search Results - "Satwani P"

A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.

Authors: Satwani, P Ahn, K W Carreras, J et al.

Source: Bone Marrow Transplantation. Nov2015, Vol. 50 Issue 11, p1416-1423. 8p. 4 Charts, 2 Graphs.

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

Authors: Satwani, P Jin, Z Martin, P L et al.

Source: Leukemia (08876924). Feb2015, Vol. 29 Issue 2, p448-455. 8p.

Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.

Authors: Satwani, P. Cooper, N. Rao, K. et al.

Source: Bone Marrow Transplantation. Jan2008, Vol. 41 Issue 2, p173-182. 10p. 1 Diagram, 3 Charts, 4 Graphs.

Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.

Authors: Bradley, M. B. Satwani, P. Baldinger, L. et al.

Source: Bone Marrow Transplantation. Oct2007, Vol. 40 Issue 7, p621-631. 11p. 4 Charts, 4 Graphs.

A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients.

Authors: Del Toro, G. Satwani, P. Harrison, L. et al.

Source: Bone Marrow Transplantation. Mar2004, Vol. 33 Issue 6, p613-622. 10p. 2 Charts, 3 Graphs.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (AlloSCT) In Children and Adolescent Recipients is Associated With Very Low Regimen Related and Non-Relapse Mortality (NRM): However, Chemonaive Patients Following Umbilical Cord Blood Transplant (UCBT) have a Higher Incidence of Primary Graft Failure (PGF)

Authors: Satwani, P. Tallamy, B. Jin, Z. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2009 Supplement, Vol. 15, p75-76. 2p.

355: Immunophenotypic and proteomic characterization of cord blood (CB) CD56^bright and CD56^dim NK cells: Potential role of CB CD56^dim mediating GVL effect

Authors: Shereck, E. Satwani, P. van de Ven, C. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2007 Supplement, Vol. 13, p128-129. 2p.

341: Reduced-intensity allogeneic umbilical cord blood transplantation (RI-UCBT) in pediatric recipients with malignant and non-malignant diseases

Authors: Satwani, P. Bradley, M.B. Baldinger, L. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2007 Supplement, Vol. 13, p123-124. 2p.

22: Ex-vivo expansion (EvE) of previously cryopreserved cord blood (CB) into natural killer (NK) cells with enhanced AML and neuroblastoma cytotoxicity: Potential role of CB NK cells in adoptive cellular immunotherapy (ACI)

Authors: Ayello, J. Satwani, P. van de Ven, C. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2007 Supplement, Vol. 13, p10-11. 2p.

Activation and enhancement of ex vivo (EvE) expanded cryopreserved Cord Blood (CB) Natural Killer (NK) cells, cytolytic potential, and NK receptor (NKR) expression: Potential role for CB NK in Adoptive Cellular Immunotherapy (ACI)

Authors: Ayello, J. Satwani, P. Lomazow, W. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2006 Supplement 1, Vol. 12, p103-104. 2p.

A Phase I Study of Gemtuzumab Ozogamicin in Combination With a Myeloablative Conditioning (MAC) Regimen and alloSCT in Children With High-Risk CD33+ AML: A New Targeted Immunochemotherapy Conditioning Regimen (GO-BU/CY)

Authors: Satwani, P. Dela Cruz, F. Le Gall, J. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2011 Supplement, Vol. 17 Issue 2, pS247-S247. 1p.

Romedepsin (RM), A Hdaci, Significantly Increases The Expression Of NKG2D Ligands, MIC A/B, In Leukemia/Lymphoma Cells (LL), In Part Through The Glycogen Synthase Kinase-3 (GSK-3) Pathway, Resulting In Enhanced NK Cytotoxicity: Translational Approach For Adoptive NK Cell Immunotherapy

Authors: Satwani, P. Saha, A. Bavishi, S. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2010 Supplement 2, Vol. 16 Issue 2, pS310-S310. 1p.

Kidney Injury (KI) In Pediatric Recipients Of Allogeneic Stem Cell Transplant (AlloSCT): Risk Of KI Is Greater With Myeloablative Conditioning (MAC) Than With Reduced Intensity Conditioning (RIC) In First Month Following AlloSCT

Authors: Satwani, P. Bavishi, S. Jin, Z. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2010 Supplement 2, Vol. 16 Issue 2, pS259-S259. 1p.

Enhanced In Vitro Expression Of NKG2D Ligands MIC A And MIC B With Histone Deacetylase Inhibitor (HDACi) Romidepsin In Pediatric Leukemia And Lymphomas: Potential for Natural Killer Cell Mediated Targeted Adoptive Cellular Immunotherapy (ACI)

Authors: Satwani, P. Saha, A. Bavishi, S. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2009 Supplement, Vol. 15, p141-141. 1p.

Comparison of Incidence of Systemic Viral Infection (SVI) and Invasive Fungal Infection (IFI) in Children Receiving Busulfan Based Reduced Intensity Allogeneic Stem Cell Transplant (RIAlloSCT) vs. Myeloablative AlloSCT (MA-AlloSCT) for Malignant and Non-Malignant Diseases

Authors: Satwani, P. Freedman, J. Baldinger, L. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2008 Supplement 2, Vol. 14 Issue 2, p96-96. 1p.

Lung Biopsy (Bx) has a Significantly Higher Diagnostic Yield Compared to Bronchoalveolar Lavage (BAL) in Pediatric Hematopoietic Stem Cell Transplant (HSCT) Recipients

Authors: Cooney-Qualter, E. Satwani, P. van de Ven, C. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2008 Supplement 2, Vol. 14 Issue 2, p26-26. 1p.

163: Systemic viral and fungal infections are not significantly decreased following reduced intensity allogeneic stem cell transplantation (RIAlloSCT) in children and adolescent recipients with malignant and nonmalignant diseases

Authors: Guerra, J. Satwani, P. Baldinger, L. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2007 Supplement, Vol. 13, p61-61. 1p.

3: Reduced intensity (RI) allogeneic cord blood hematopoietic cell transplantation (Allo-CBHCT) in pediatric patients with malignant and non-malignant diseases

Authors: Satwani, P. Del Toro, G. Bradley, M. et al.

Source: Biology of Blood & Marrow Transplantation. Nov2006, Vol. 12 Issue 11, p1218-1218. 1p.

Significant increase in cord blood (CB) vs peripheral blood (PB) alloantigen specific T-regulatory (T-Reg) (CD4⁺/CD25⁺/CTLA4⁺) cells following antigen presenting cell (APC) induction: Molecular, functional and immunophenotypic characterization

Authors: Cairo, M.S. Satwani, P. Oberfield, N. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2006 Supplement 1, Vol. 12, p50-50. 1p.

Reduced intensity conditioning and allogeneic stem cell transplantation (RIAlloSCT) from unrelated cord blood and matched family donors in children and adolescent recipients results in sustained donor chimerism

Authors: Del Toro, G. Satwani, P. Harrison, L. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2004 Supplement 1, Vol. 10, p76. 1p.